Kinetics of D-dimer after general surgery

Blood Coagul Fibrinolysis. 2009 Jul;20(5):347-52. doi: 10.1097/MBC.0b013e32832a5fe6.

Abstract

D-dimers may be elevated after surgery. However, the kinetics of postoperative D-dimers remains unknown hampering the use of D-dimer testing in surgical patients with suspected venous thromboembolism. D-dimer levels were prospectively measured in 154 patients after general surgery at predefined time points (kinetics were determined in an initial cohort of 108 patients; for validation, these findings were applied to a second cohort of 46 patients). Clinical factors influencing the peak of D-dimers were analyzed using multivariate regression. Surgical operations were stratified based on severity (type I: not entering abdominal cavity; type II: intraabdominal; type III: retroperitoneal/liver surgery). D-dimer levels increased postoperatively reaching a peak on day 7. After type I surgery, peak D-dimer levels did not exceed normal range (300 ng/ml, 100-500). After type II procedures, peak D-dimer level was 1500 ng/ml (200-7800) and returned to normal values after 25 days (+/-14). Peak level was 4000 ng/ml (500-14 400) after type III surgery normalizing within 38 days (+/-11). Clearance of D-dimer was exponential after having reached the peak with 6.0% per day (95% confidence interval 4.8-7.1%). By this clearance, D-dimer values could be adequately predicted in the validation cohort after day 7 (r2 = 0.63). Peak D-dimer levels were independently influenced by the type of surgery (P < 0.001), the operation time (P < 0.001) and by preoperatively elevated D-dimer levels (P < 0.001). Based on this data, duration of postoperative D-dimer elevation after abdominal surgery is predictable. This study indicates for the first time when D-dimers may be used again in the diagnostic algorithm for venous thromboembolism exclusion after surgery in patients with low or moderate clinical probability.

MeSH terms

  • Abdomen / surgery
  • Abdominal Neoplasms / blood
  • Abdominal Neoplasms / surgery
  • Adult
  • Aged
  • Anticoagulants / therapeutic use
  • Cohort Studies
  • Dalteparin / therapeutic use
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Humans
  • Incidence
  • Kinetics
  • Male
  • Middle Aged
  • Postoperative Complications / blood*
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Postoperative Complications / prevention & control
  • Postoperative Period
  • Prospective Studies
  • Pulmonary Embolism / epidemiology
  • Pulmonary Embolism / etiology
  • Stockings, Compression
  • Thrombophilia / blood*
  • Thrombophilia / drug therapy
  • Thrombophilia / etiology
  • Venous Thrombosis / epidemiology
  • Venous Thrombosis / etiology
  • Venous Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Dalteparin